Tracking Status Report
Antonio Ciaccia
Tracking group: OPA Legislation Tracker
dextromethorphan sales
Koehler, K.
To prohibit sales of dextromethorphan without a prescription to persons under age 18.
Text & Analysis
Committee Hearing
in Senate Local Government, Public Safety & Veterans Affairs Committee (12/16/2020; REPORTED (No testimony))
veteran health care
Holmes, G. Perales, R.
To require certain entities to inform veterans about health care benefits available to all veterans.
Text & Analysis
Introduced and Referred
in House (2/12/2019; Armed Services & Veterans Affairs Committee)
drug information
Lipps, S. West, T.
Regarding pharmacy benefit managers, pharmacists, and the disclosure to patients of drug price information.
Text & Analysis
Committee Hearing
in House Health Committee (6/4/2019; REPORTED (No testimony))
immunizations
Manning, D.
Regarding notice of school child immunization requirements and exemptions.
Text & Analysis
Committee Hearing
in House Primary & Secondary Education Committee (4/2/2019; CONTINUED)
HB 166
Enacted
state budget
Oelslager, S.
To make operating appropriations for the biennium beginning July 1, 2019, and ending June 30, 2021, and to provide authorization and conditions for the operation of state programs.
Text & Analysis
Signed by the Governor
(7/18/2019; Signed: July 18, 2019 with vetoes; Delivered to the governor July 17, 2019)
HB 203
Enacted
dental facilities
Lipps, S.
To specify requirements for the operation of mobile dental facilities and to authorize pharmacists to enter consult agreements with certain physician assistants and advanced practice registered nurses.
Text & Analysis
Signed by the Governor
(9/16/2020; Signed: September 16, 2020; Effective: in 90 days)
prescription readers
Brown, R.
Regarding prescription drug readers for visually impaired patients.
Text & Analysis
Committee Hearing
in House Health Committee (1/21/2020; CONTINUED)
vaccinations
Hood, R.
To enact the "Medical Consumer Protection Act" to prohibit an employer from taking an adverse employment action against a person who has not been or will not be vaccinated.
Text & Analysis
Referred
in House (6/4/2019; Commerce & Labor Committee)
health care
Skindell, M. Kent, B.
To establish and operate the Ohio Health Care Plan to provide universal health care coverage to all Ohio residents.
Text & Analysis
Committee Hearing
in House Health Committee (9/10/2019; CONTINUED (See separate story))
HB 341
Enacted
addiction treatment
Ginter, T.
Regarding the administration of addiction treatment drugs, federal agency access to the Ohio Automated Rx Reporting System, the Board of Pharmacy's exemption from open meetings requirements, the occasional sale of certain drugs at wholesale, and naloxone access and education.
Text & Analysis
Signed by the Governor
(9/16/2020; Signed: September 16, 2020; Effective: in 90 days)
insulin cost report
Liston, B.
To require the Attorney General to investigate insulin pricing and prepare and submit a report.
Text & Analysis
Committee Hearing
in House Health Committee (2/11/2020; CONTINUED)
insulin cost-sharing
Liston, B. Boggs, K.
To cap cost-sharing for prescription insulin drugs.
Text & Analysis
Committee Hearing
in House Health Committee (2/18/2020; CONTINUED)
pharmacy benefit managers
Galonski, T.
To impose requirements on pharmacy benefit managers.
Text & Analysis
Committee Hearing
in House Health Committee (1/14/2020; CONTINUED (See separate story))
HB 412
Enacted
disease council
Clites, R. Ginter, T.
To establish the Rare Disease Advisory Council.
Text & Analysis
Signed by the Governor
(12/21/2020; Signed: December 21, 2020, Effective: March 20, 2021; earlier undefined)
medication switching
Carruthers, S.
Regarding prescription drugs and medication switching.
Text & Analysis
Committee Hearing
in House Health Committee (12/1/2020; REPORTED-AMENDED)
emergency prescriptions
Manning, G.
To increase the frequency at which a pharmacist may refill certain prescriptions on an emergency basis and to require health benefit plans to cover drugs dispensed in those situations.
Text & Analysis
Committee Hearing
in House Health Committee (1/21/2020; CONTINUED)
occupational licensing
Powell, J. Lang, G.
To require an occupational licensing authority to issue a license or government certification to an applicant who holds a license, government certification, or private certification or has satisfactory work experience in another state under certain circumstances.
Text & Analysis
Committee Hearing
in House State & Local Government Committee (1/29/2020; CONTINUED)
medicaid managed care
Lang, G.
To require Medicaid managed care organizations to engage in a competitive selection process when contracting with a laboratory services provider vendor.
Text & Analysis
Committee Hearing
in House Health Committee (11/10/2020; CONTINUED)
health insurance
West, T.
To prohibit certain health insurance cost-sharing practices.
Text & Analysis
Committee Hearing
in House Health Committee (12/15/2020; CONTINUED)
drug pricing
Manchester, S.
To prohibit a pharmacy benefit manager from taking certain actions with respect to reimbursements made to health care providers that participate in the federal 340B Drug Pricing Program.
Text & Analysis
Committee Hearing
in House Health Committee (12/1/2020; REPORTED-AMENDED)
HB 606
Enacted
civil immunity
Grendell, D.
To make temporary changes related to qualified civil immunity for health care and emergency services provided during a government-declared disaster or emergency and for exposure to or transmission or contraction of certain coronaviruses.
Text & Analysis
Signed by the Governor
(9/14/2020; Signed: September 14, 2020; Effective: in 90 days)
business practices
Roemer, B.
Regarding the operation of businesses, practice of certain professions, completion of education as it relates to COVID-19, public health, and membership of the State Cosmetology and Barber Board, to modify the electric utility law regarding energy efficiency programs, and to declare an emergency.
Text & Analysis
Informally Passed
in Senate (12/22/2020)
To establish and modify requirements regarding the provision of telehealth services and to declare an emergency.
Text & Analysis
Committee Hearing
in House (11/18/2020; CONTINUED)
Committee Hearing
in Senate Insurance & Financial Institutions Committee (11/18/2020; CONTINUED)
prescription opiates
Holmes, A. Crossman, J.
Regarding reducing the abuse of prescription opiates
Text & Analysis
Referred
in House (8/31/2020; Health Committee)
addiction treatment
Holmes, A. Crossman, J.
Regarding making addiction treatment widely available
Text & Analysis
Referred
in House (8/31/2020; Health Committee)
SB 9
Enacted
claim information
Huffman, M.
To require health plan issuers to release certain claim information to group plan policyholders.
Text & Analysis
Signed by the Governor
(1/8/2021; Signed: January 8, 2021, Effective: in 90 days)
drug information
Maharath, T.
Regarding pharmacy benefit managers, pharmacists, and the disclosure to patients of drug price information.
Text & Analysis
Committee Hearing
in Senate Insurance & Financial Institutions Committee (4/3/2019; CONTINUED)
controlled substances
Maharath, T.
Regarding the disposal of controlled substances.
Text & Analysis
Committee Hearing
in Senate Health, Human Services & Medicaid Committee (4/10/2019; CONTINUED)
SB 24
Enacted
alzheimer's disease
Wilson, S. Yuko, K.
To establish the Alzheimer's Disease and Related Dementias Task Force.
Text & Analysis
Signed by the Governor
(11/6/2019; Signed: November 6, 2019; Effective: in 90 days)
medicaid copayments
Dolan, M.
Regarding Medicaid copayment requirements.
Text & Analysis
Committee Hearing
in Senate Health, Human Services & Medicaid Committee (2/19/2019; CONTINUED)
drug prescribing
Maharath, T.
Regarding non-opioid directives and non-opioid therapies.
Text & Analysis
Committee Hearing
in Senate Health, Human Services & Medicaid Committee (5/1/2019; CONTINUED)
SB 57
Enacted
to establish conditions and requirements governing the regulation of hemp and hemp products, to amend the version of section 109.572 that is scheduled to take effect on September 20, 2019, and the versions of sections 3719.01, 3719.41, and 4729.01 of the Revised Code that are scheduled to take effect on March 22, 2020, to continue the provisions of this act on and after those dates, and to declare an emergency.
Text & Analysis
Signed by the Governor
(7/30/2019; Signed: July 30, 2019)
naloxone dispensing
Antonio, N.
To require the State Board of Pharmacy to educate license holders about the law authorizing naloxone dispensing without a prescription.
Text & Analysis
Committee Hearing
in House Health Committee (6/2/2020; REPORTED)
cultural competency
Maharath, T.
To require certain health care professionals to complete instruction in cultural competency.
Text & Analysis
Committee Hearing
in Senate Health, Human Services & Medicaid Committee (4/10/2019; CONTINUED)
health services
Huffman, S.
Regarding the provision of cost estimates for scheduled health care services and health care services requiring insurer preauthorization.
Text & Analysis
Committee Hearing
in House Health Committee (12/1/2020; REPORTED)
sexual contact
Kunze, S. Craig, H.
To prohibit unlawful sexual contact between health care professionals and patients and to revoke professional licenses for criminal misconduct.
Text & Analysis
Committee Hearing
in Senate Judiciary Committee (10/2/2019; CONTINUED)
SB 178
Enacted
flu shots
Schuring, K.
Regarding the authority of podiatrists to administer influenza vaccinations.
Text & Analysis
Signed by the Governor
(11/27/2020; Signed: November 27, 2020, Effective: in 90 days)
network care
Huffman, S. Antonio, N.
Regarding out-of-network care.
Text & Analysis
Committee Hearing
in Senate Insurance & Financial Institutions Committee (12/11/2019; CONTINUED (See separate story))
insulin cost report
Craig, H. Antonio, N.
To require the Attorney General to investigate insulin pricing and prepare and submit a report.
Text & Analysis
Committee Hearing
in Senate Finance: Health & Medicaid Subcommittee (2/25/2020; CONTINUED)
insulin cost-sharing
Craig, H. Antonio, N.
To cap cost-sharing for prescription insulin drugs.
Text & Analysis
Committee Hearing
in Senate Finance: Health & Medicaid Subcommittee (2/25/2020; CONTINUED)
occupational licensing
Roegner, K. McColley, R.
To require an occupational licensing authority to issue a license or government certification to an applicant who holds a license, government certification, or private certification or has satisfactory work experience in another state under certain circumstances.
Text & Analysis
Committee Hearing
in Senate General Government & Agency Review Committee (12/17/2020; CONTINUED)
SB 252
Enacted
drug treatment
Craig, H. Hackett, B.
To prohibit "fail first" coverage of drugs used to treat stage four advanced metastatic cancer.
Text & Analysis
Signed by the Governor
(12/21/2020; Signed: December 21, 2020, Effective: March 20, 2021)
SB 263
Enacted
drug pricing
Hackett, B.
To prohibit a pharmacy benefit manager from taking certain actions with respect to reimbursements made to health care providers that participate in the federal 340B Drug Pricing Program.
Text & Analysis
Signed by the Governor
(1/6/2021; Signed: January 6, 2021, Effective: in 90 days)
pharmacist agreements
Huffman, S. Manning, N.
Regarding pharmacist consult agreements.
Text & Analysis
Committee Hearing
in House Health Committee (6/9/2020; CONTINUED)
telemedicine
Craig, H.
To require health plan issuers to cover telemedicine services during a state of emergency and to declare an emergency.
Text & Analysis
Committee Hearing
in Senate Insurance & Financial Institutions Committee (12/1/2020; CONTINUED)
civil immunity
Huffman, M.
To revise the law governing immunity from civil liability and professional discipline for health care providers during disasters or emergencies, to provide qualified civil immunity to service providers providing services during and after a government-declared disaster, and to declare an emergency.
Text & Analysis
Referred
in House (6/10/2020; Civil Justice Committee)
Copyright 2024, Gongwer News Service, Inc. All rights reserved.
Terms of ServicePrivacy Policy